85 results
Page 2 of 5
SC TO-T
EX-99
4ltpsm6k4aci8ia6jud
1 Dec 22
Third party tender offer statement
6:06am
8-K
EX-99.1
0ezo0kno pa9luz
29 Nov 22
Viatris Completes Biosimilars Transaction with Biocon Biologics
8:29am
SC TO-C
EX-99.2
wavqxlb
7 Nov 22
Information about tender offer
5:26pm
SC TO-C
EX-99.1
4muupi6bs3r5ffptp
7 Nov 22
Information about tender offer
5:26pm
8-K
EX-99.1
08s8rol 74mfu410
7 Nov 22
Expects Biocon Biologics Transaction to Close Shortly
9:07am
8-K
EX-99.2
hvq82m1l
7 Nov 22
Expects Biocon Biologics Transaction to Close Shortly
9:07am
8-K
EX-99.1
cb9086yl84lqa
7 Nov 22
Viatris Reports Strong Third Quarter 2022 Results
7:41am
8-K
EX-99.1
bj0qu
8 Aug 22
Viatris Reports Strong Second Quarter 2022 Results
8:02am
8-K
EX-99.1
opzn349rb
9 May 22
Viatris Reports Strong First-Quarter 2022 Results
8:15am
8-K
EX-2.1
r9wl da3ib
28 Feb 22
Entry into a Material Definitive Agreement
4:39pm
8-K
EX-99.1
tg2ugm
28 Feb 22
Viatris Reports Strong Fourth Quarter and Full-Year 2021 Financial Results and Issues 2022 Financial Guidance
8:24am
8-K
EX-99.1
wof xj5zv
8 Nov 21
Viatris Reports Strong Third Quarter Results, Raises 2021 Financial Guidance and Board of Directors Declares Quarterly Dividend of Eleven Cents ($0.11) per Share
8:27am
DEF 14A
7rokje8ah5 i91tc8
29 Oct 21
Definitive proxy
4:35pm